MBX Stock Analysis: Buy, Sell, or Hold?
MBX - MBX Biosciences, Inc. Common Stock
$36.85
0.01 (0.03%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 16, 2026
Get Alerted When MBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MBX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MBX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MBX is currently trading at $36.85, which is considered fair relative to its 30-day fair value range of $30.85 to $39.84.
Technical Outlook: Technically, MBX is in a strong uptrend. Immediate support is located at $35.00, while resistance sits at $43.98.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.10 (+65.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MBX is in a strong uptrend. Immediate support is located at $35.00, while resistance sits at $43.98.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.10 (+65.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$30.85 -
$39.84
Company Quality Score
58/100
(HOLD)
Options IV Signal
40th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 40th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.8% below Wall St target ($61.10)
Fair Price Analysis
30-Day Fair Range
$30.85 -
$39.84
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$5.42
(14.7%)
Support & Resistance Levels
Support Level
$35.00
Resistance Level
$43.98
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-12.02
Wall Street Target
$61.10
(+65.8%)
Last updated: February 01, 2026 12:51 AM ET
Data refreshes hourly during market hours. Next update: 1:51 AM
Data refreshes hourly during market hours. Next update: 1:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MBX showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
P. Kent Hawryluk
BUY
20000 shares
2025-10-20
Steven L Hoerter
BUY
20000 shares
2025-10-17
Patrick J Heron
BUY
666666 shares
2025-09-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
Advanced MBX Option Strategies
Professional options setups generated by AI based on today's MBX price and gamma walls.
